Effects of a chronic lithium treatment on cortical serotonin uptake sites and 5-HT1A receptors

Neurochemical Research

Volumn 22, Issue 4, 1997, Pages 427-435

  Carli, Martin ^a   Afkhami Dastjerdian, Soheila ^a   Reader, Tomás A ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

5 ht1a receptor; Lithium; Serotonin uptake

Indexed keywords

2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 5 HYDROXYINDOLEACETIC ACID; AMINE OXIDASE (FLAVIN CONTAINING); CITALOPRAM; LITHIUM;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN CORTEX; CINGULATE GYRUS; CONTROLLED STUDY; DRUG RECEPTOR BINDING; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SEROTONINERGIC SYSTEM;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; CELL MEMBRANE; CEREBRAL CORTEX; CITALOPRAM; HUMANS; HYDROXYINDOLEACETIC ACID; LITHIUM; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TRITIUM;

ANIMALIA;

EID: 0030891571     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027355626355     Document Type: Article

References (13)

1. Cade, J. F. J. 1949. Lithium salts in the treatment of psychotic excitement. Med. J. Aust. 36:349-352.
2. Schildkraut, J. J. 1965. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiat. 122: 509-522.
3. 3H-norepinephrine metabolism in brain. Life Sci. 5:1479-1483.
4. Coppen, A. J. 1967. The biochemistry of affective disorder. Brit. J. Psychiat. 113:1237-1264.
5. Prange, A. J., Wilson, I. C., and Lynn, C. W. 1974. L-tryptophan in mania: contribution to a permissive hypothesis of affective disorders. Arch. Gen. Psychiat. 30:56-62.
6. Goodwin, F. K., and Post, R. M. 1983. 5-Hydroxytryptamine and depression: a model for the interaction of normal variance with pathology. Brit. J. Clin. Pharmacol. 15:393S-405S.
7. de Montigny, C., Cournoyer, G., Morissette, R., Langlois, R., and Caillé, G. 1983. Lithium carbonate addition in tricyclic antide-pressant-resistant depression: correlations with the neurobiologic actions of tricyclic antidepressant drugs and the lithium ion on the serotonin system. Arch. Gen. Psychiat. 40:1327-1334.
8. Heninger, G. R., Charney, D. S., and Sternberg, D. E. 1983. Lithium carbonate augmentation of antidepressant treatment: an effective prescription for treatment-refractory depression. Arch. Gen. Psychiat. 40:1335-1342.
9. Price, L. H., Charney, D. S., Delgado P., and Heninger, G. R. 1990. Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacol. 100:3-12.
10. Schorderet, M. 1977. Lithium inhibition of cyclic AMP accumulation induced by dopamine in isolated retinae of the rabbit. Biochem. Pharmacol. 26:167-180.
11. Gottberg, E., Montreuil, B., and Reader, T. A. 1988. Acute effects of lithium on dopaminergic responses. Iontophoretic studies in the rat visual cortex. Synapse 2:442-449.
12. Carli, M., Anand-Srivastava, M. B., Molina-Holgado, E., Dewar, K. M., and Reader, T. A. 1994. Effects of chronic lithium treatments on central dopaminergic receptor systems: G proteins as possible targets. Neurochem. Int. 24:13-22.
13. 3H]8-hydroxy-2-(di-n-Propylamino)tetralin binding to pre- and postsynaptic 5-hydroxy-tryptamine sites in various regions of the rat brain. J. Neurochem. 44:1685-1696.